Cure
PrivateLast Round
Series A
Sep 15, 2022
Total Funding Raised
$19.6M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Cure operates in Healthcare & Life Sciences and is based in Berlin. Its latest recorded funding round was a Series A round in September 2022.
Cure is a digital health company that provides an AI-driven platform for the on-demand delivery of medications and telehealth services.
Sector
Healthcare & Life Sciences
Verticals
E-commerce, Last-Mile Delivery, Telemedicine, Retail Technology
Business Model
B2B2C
Customer Profile
Marketplace Commission, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cure Comparables
Compare Cure with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Apoly GmbH | 84% | |
| Pharmao | 78% | |
| Joom | 77% |
For institutional investors. Book with your work email.
Cure Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 15, 2022 | ||||
| Seed | Jan 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cure Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| J12 Ventures | Seed, Series A |
| J Ventures | Seed, Series A |
| Craft Ventures | Seed, Series A |
| Breega | Series A |
| Pi Labs | Series A |
| Abstract Ventures | Seed, Series A |
| Abstract Ventures | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2026
Open roles increased to 21, 95% of headcount.
- Sep 1, 2026
Open roles increased to 21, 95% of current headcount.
For institutional investors. Book with your work email.
Cure Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cure's valuation, stock price, and market status.
Is Cure a public or private company?
Cure is a private company.
What is the current stock price of Cure?
Cure is a private company, so its shares have no public market price. Caplight tracks Cure's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cure worth (valuation)?
Valuation information for Cure is not publicly available.
Can I buy Cure stock?
Cure shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cure's last funding round?
Cure's most recent funding round was Series A on September 15, 2022.
Who are the main investors in Cure?
Key investors in Cure include Breega.
Will Cure IPO soon?
No public IPO plans have been announced for Cure.
How can I track Cure secondary market activity?
Caplight tracks bids, offers, and trades in Cure's shares on secondary markets.